trap-1

TRAP-1 (XJZ-06-462) 作为一种p53转录激活剂，能够有效地在突变p53中触发p53靶基因的转录活性。在胰腺细胞系p53Y220C中，该化合物能迅速提高p21等p53靶基因的表达水平。此外，TRAP-1 在BxPC-3和A549细胞线中显示出抑制细胞增殖的效果，其半抑制浓度(IC50)分别为3.94和0.531 μM。该化合物还能促进肺癌细胞的自噬作用，并在氧化应激和细胞凋亡方面提供保护。

PU-H54 是一种基于嘌呤的 Grp94 抑制剂。它是一种基于 Grp94 选择性间苯二酚的抑制剂，通过探测 Grp94 中 S2 亚袋的专有结合区而分离。

TRAP1-IN-1（化合物35）是一种高效、具有高选择性的TRAP1抑制剂，其中TRAP1为Hsp90蛋白质家族中的一种线粒体同源体。该抑制剂对TRAP1的选择性优于Grp94超过250倍，能够破坏TRAP1四聚体的稳定性，并诱导下游蛋白质的降解。此外，TRAP1-IN-1能够抑制线粒体氧化磷酸化复合体（OXPHOS），破坏线粒体膜电位，并促进糖酵解过程。

TRAP1-IN-2（化合物36）作为TRAP1下游蛋白的选择性降解剂，不会对Hsp90的胞质下游蛋白产生影响。同时，该化合物还能抑制OXPHOS，导致细胞糖酵解代谢的变化。此外，TRAP1-IN-2会破坏TRAP1四聚体的稳定性，并影响线粒体膜电位。

nociceptin orphanin FQ (NOP) receptor antagonist

Luminespib (VER-52296) 是一种 HSP90 抑制剂，抑制 HSP90α 和 HSP90β (IC50=7.8 21 nM)。Luminespib 具有抗肿瘤活性，用于头颈部肿瘤等的研究。

SNX2112 (PF 04928473) 是一种具有口服活性的 Hsp90 抑制剂，Kd 为 16 nM。

NVP-HSP990 (HSP990) 是一种选择性的Hsp90抑制剂，对 Hsp90α、Hsp90β 和 Grp94 的IC50值分别为 0.6、0.8 和 8.5 nM。

VER-82576 (NVP-BEP800) 是一种可口服的，选择性的 Hsp90抑制剂，对 Hsp90β 的 IC50值为 58 nM，对 Hsp90 家族成员 Trap-1 和 Grp94 的选择性超过 70 倍。

PU-WS13 是一种活性分子，可用于生命科学相关研究，其 CAS 号为 1454619-14-7。

SW02 是一种有效的 Hsp70 的 ATPase 活性激活剂 (EC50: 150 μM)。SW02 能够积累总 tau 和磷酸化 tau (pTau)。

DP-1 hydrochloride是 SDC-TRAP-0063 的降解产物，是 Ganetespib 的一个片段。Ganetespib 是一种具有抗肿瘤活性的热休克蛋白 90 (HSP90) 抑制剂。

DMPO (5,5-Dimethyl-1-pyrroline N-oxide) 是一种亲水自旋诱捕剂，具有细胞渗透性。DMPO 可用于超氧化物检测，可检测超氧阴离子和羟自由基。

Vorapaxar (MK-5348) 是抗血小板药物，是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂，Ki 值为 8.1 nM。它靠剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集。

NFAT Inhibitor (VIVIT peptide) 是NFAT 的细胞渗透性肽抑制剂，能够选择性抑制钙调磷酸酶介导的NFAT 脱磷酸作用。

TRAP-6 amide acetate 是一种 PAR-1 凝血酶受体激动剂肽。

Vorapaxar sulfate (Zontivity) 是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂，Ki 值为 8.1 nM。它剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集，是抗血小板药物。

TRAP-6 peptide is a hexapeptide corresponding to residues 42-47 of protease-activated receptor 1 (PAR1). It acts as an agonist of PAR1, inducing platelet aggregation in human platelet-rich plasma ex vivo (EC50 = 0.8 μM). TRAP-6 (0.3 and 0.6 mg kg) has a triphasic effect on mean arterial blood pressure (MAP) in anesthetized rats with a short decrease, an increase, and then a longer decrease in MAP following intravenous administration.

2-chloro Palmitic acid is a monochlorinated form of palmitic acid . It is produced in a myeloperoxidase (MPO) and time-dependent manner in neutrophils stimulated by phorbol 12-myristate 13-acetate . 2-chloro Palmitic acid (10 μM) induces neutrophil extracellular trap (NET) formation (NETosis) in human neutrophils, increasing DNA release from neutrophils, colocalization of MPO with extracellular DNA (ecDNA), and trapping of E. coli. It increases COX-2 protein levels in human coronary artery endothelial cells (HCAECs) when used at a concentration of 50 μM and increases production of P-selectin, von Willebrand factor, and angiopoietin-2 in HCAECs, as well as neutrophil and platelet adherence, when used at a concentration of 10 μM. 2-chloro Palmitic acid (10-50 μM) also induces apoptosis in THP-1 cells and primary human monocytes and increases caspase-3 activity in THP-1 cells.

CYPMPO is a free radical spin trap with excellent trapping capabilities toward hydroxyl and superoxide radicals in biological and chemical systems. Decay of the superoxide adduct of CYPMPO proceeds in an apparent first order fashion with half-lives of 15 and 51 minutes in a UV-illuminated hydrogen peroxide solution and a hypoxanthine/xanthine oxidase system, respectively. CYPMPO traps superoxide radicals generated by bovine neutrophils as effectively as DEPMPO.[1] The high melting point (126°C), low hygroscopic properties, and long shelf-life in aqueous solutions offer significant practical advantages for use of CYPMPO over DEPMPO and DMPO.

Thrombin receptor agonist peptide (TRAP-14) is a 14-amino acid peptide agonist of the α-thrombin receptor. It induces aggregation of washed platelets as well as platelets in citrated and hirudin plasma. TRAP-14 (100 μM) increases the cytosolic calcium concentration in isolated guinea pig pulmonary smooth muscle cells 5-fold over baseline. It increases pulmonary arterial pressure in isolated guinea pig lung when used at a concentration of 1 μM, which is comparable to the effect induced by 10 nM α-thrombin. TRAP-14 also induces contraction of isolated rat aortic rings and increases endothelin-1 (ET-1) levels in a dose-dependent manner, an effect that is reversed by the ETA antagonist BQ-123 and the nitric oxide synthase (NOS) inhibitor L-NNA .

9(Z)-Pentacosene is a cuticular hydrocarbon and insect sex hormone.1,2,3 It is found in the cuticle of female F. canicularis flies and is an attractant to males in a trap assay.1 9(Z)-Pentacosene is a contact sex hormone in scarab beetles and locust borers that is more abundant in females than males.2,3 It elicits arrestment, alignment, and mounting by males of both species in mating assays but only elicits copulation by the locust borer. 9(Z)-Pentacosene is also produced by the orchid O. exaltata and by C. cunicularius, a pollinator of O. exaltata.4

TRAP-6 amide is a PAR-1 thrombin receptor agonist peptide.

TRAP-6 amide TFA is a PAR-1 thrombin receptor agonist peptide.